Literature DB >> 9703519

HIV and hepatitis C among injecting drug users.

R A Coutinho.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9703519      PMCID： PMC1113707          DOI： 10.1136/bmj.317.7156.424

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Interventions among injecting drug users: do they work?

Authors:  E J van Ameijden; J K Watters; J A van den Hoek; R A Coutinho
Journal:  AIDS       Date:  1995       Impact factor: 4.177

Review 2.  Transmission of hepatitis C virus: rates, routes, and cofactors.

Authors:  M MacDonald; N Crofts; J Kaldor
Journal:  Epidemiol Rev       Date:  1996       Impact factor: 6.222

Review 3.  Hepatitis C virus six years on.

Authors:  C L van der Poel; H T Cuypers; H W Reesink
Journal:  Lancet       Date:  1994-11-26       Impact factor: 79.321

4.  Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group.

Authors:  O Reichard; G Norkrans; A Frydén; J H Braconier; A Sönnerborg; O Weiland
Journal:  Lancet       Date:  1998-01-10       Impact factor: 79.321

5.  Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.

Authors:  I van Beek; R Dwyer; G J Dore; K Luo; J M Kaldor
Journal:  BMJ       Date:  1998-08-15

6.  Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group.

Authors:  J I Tokars; R Marcus; D H Culver; C A Schable; P S McKibben; C I Bandea; D M Bell
Journal:  Ann Intern Med       Date:  1993-06-15       Impact factor: 25.391

7.  Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users.

Authors:  H J van Haastrecht; E J van Ameijden; J A van den Hoek; G H Mientjes; J S Bax; R A Coutinho
Journal:  Am J Epidemiol       Date:  1996-02-15       Impact factor: 4.897
  7 in total
  19 in total

1.  Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?

Authors:  V D Hope; A Judd; M Hickman; T Lamagni; G Hunter; G V Stimson; S Jones; L Donovan; J V Parry; O N Gill
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

2.  Minimising harm from hepatitis C virus needs better strategies.

Authors:  N Crofts; S Caruana; S Bowden; M Kerger
Journal:  BMJ       Date:  2000-10-07

3.  Ignoring 'downstream infection' in the evaluation of harm reduction interventions for injection drug users.

Authors:  H A Pollack
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

4.  Using simulation for AIDS policy modeling: benefits for HIV/AIDS prevention policy makers in Vienna, Austria.

Authors:  Marion S Rauner
Journal:  Health Care Manag Sci       Date:  2002-04

5.  The impact of hepatitis C in general practice.

Authors:  S Singh; R Miller; S Madge; D Patch
Journal:  Br J Gen Pract       Date:  2000-07       Impact factor: 5.386

6.  Refugees, asylum seekers, and general practice: room for improvement?

Authors:  S Hargreaves; A Holmes; J S Friedland
Journal:  Br J Gen Pract       Date:  2000-07       Impact factor: 5.386

7.  Hepatitis C and general practice: the crucial role of primary care in stemming the epidemic.

Authors:  John Budd; Roy Robertson
Journal:  Br J Gen Pract       Date:  2005-04       Impact factor: 5.386

8.  Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Authors:  Benedikt Fischer; Jürgen Rehm; Suzanne Brissette; Serge Brochu; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Phil Mun; Dolly Baliunas
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

9.  Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them.

Authors:  K M Roy; S J Hutchinson; S Wadd; A Taylor; S O Cameron; S Burns; P Molyneaux; P G McIntyre; D J Goldberg
Journal:  Epidemiol Infect       Date:  2006-08-08       Impact factor: 2.451

10.  A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design.

Authors:  Marie Jauffret-Roustide; Yann Le Strat; Elisabeth Couturier; Damien Thierry; Marc Rondy; Martine Quaglia; Nicolas Razafandratsima; Julien Emmanuelli; Gaelle Guibert; Francis Barin; Jean-Claude Desenclos
Journal:  BMC Infect Dis       Date:  2009-07-16       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.